Personal information

Emails & domains

Verified email domains

Websites & social links

http://biochem.med.ufl.edu/research/primary-faculty/suming-huang/

Keywords

Chromatin, Epigenetics, Transcription

Countries

United States

Activities

Collapse all

Employment (4)

Penn State College of Medicine: Hershey, PA, US

2018-03-01 to present | Professor (Department of Pediatrics)
Employment
Source: Self-asserted source
Suming Huang

University of Florida: Gainesville, FL, US

2017-07 to 2028-02 | Professor (Biochemistry & Molecular Biology)
Employment
Source: Self-asserted source
Suming Huang

University of Florida: Gainesville, FL, US

2012-07 to 2017-06 | Associate Professor (Biochemistry & Molecular Biology )
Employment
Source: Self-asserted source
Suming Huang

University of Florida: Gainesville, FL, US

2006-06 to 2012-05 | Assistant Professor (Biochemistry & Molecular Biology)
Employment
Source: Self-asserted source
Suming Huang

Education and qualifications (3)

Mississippi State University: Mississippi State, MS, US

1992-08 to 1996-12 | PhD
Education
Source: Self-asserted source
Suming Huang

Xiamen University: Xiamen, Fujian, CN

1985-09 to 1988-06 | M.S. (Biology)
Education
Source: Self-asserted source
Suming Huang

Xiamen University: Xiamen, Fujian, CN

1979-09 to 1983-07 | B.S. (Biology)
Education
Source: Self-asserted source
Suming Huang

Funding (2)

Regulation of TAL1/SCL in T-cell leukemia

2017-02 to 2022-01 | Grant
NIH Office of the Director (MD, MD, US)
GRANT_NUMBER:

R01 CA204044
Source: Self-asserted source
Suming Huang

The role of long noncoding RNA in hematopoiesis

2016-09 to 2020-06 | Grant
NIH Office of the Director (MD, MD, US)
GRANT_NUMBER:

R01 DK110108

Source: Self-asserted source
Suming Huang

Peer review (10 reviews for 8 publications/grants)

Review activity for Advanced science. (1)
Review activity for Cell reports. (1)
Review activity for EMBO journal. (1)
Review activity for EMBO reports. (1)
Review activity for Leukemia (3)
Review activity for Nature cancer. (1)
Review activity for Oncogene. (1)
Review activity for Stem cell reviews. (1)
How many people are using ORCID?